S. Pinder

S. Pinder, A. Sever, Rajesh Balasubramian, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A consensus prognostic gene expression classifier for ER positive breast cancer

I. Ellis, C. Caldas, S. Aparicio, 2006, Genome Biology.

Histologic Grading of Breast Cancer: Linkage of Patient Outcome with Level of Pathologist Agreement

Leslie W Dalton, Ian O Ellis, William D Dupont, 2000, Modern Pathology.

Ultrasound guided core biopsy of suspicious mammographic calcifications using high frequency and power Doppler ultrasound.

I. Ellis, S. Pinder, A. Evans, 1998, Clinical radiology.

Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study

David J. Hawkes, John H. Hipwell, Daniel C. Alexander, 2016, NMR in biomedicine.

Invited Editorial

I. Ellis, S. Pinder, 1998 .

Routine audit of breast fine needle aspiration (FNA) cytology specimens and aspirator inadequate rates

I. Ellis, R. Blamey, S. Pinder, 1997, Cytopathology : official journal of the British Society for Clinical Cytology.

UK national audit of breast fine needle aspiration cytology in 1990–91: diagnostic criteria

I. Ellis, S. Pinder, C. Elston, 1996, Cytopathology : official journal of the British Society for Clinical Cytology.

Expression of luminal and basal cytokeratins in human breast carcinoma

I. Ellis, S. Pinder, J. Robertson, 2004, The Journal of pathology.

The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example

Valerie Speirs, Alastair M Thompson, S. Pinder, 2012, Journal of Clinical Pathology.

Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management

I. Ellis, P. Tan, S. Fox, 2020, Histopathology.

An Overview of Immunohistochemistry in Diagnosis of Breast Lesions

S. Pinder, F. O'Malley, T. Jacobs, 2011 .

Chapter 25 – Overview of Immunohistochemistry in Breast Lesions

S. Pinder, F. O'Malley, S. Mohsin, 2006 .

Non-operative breast pathology: lobular neoplasia

J. Reis-Filho, S. Pinder, 2006, Journal of Clinical Pathology.

Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression?: A Morphological and Molecular Analysis

I. Ellis, S. Humphreys, S. Lakhani, 2005, The American journal of surgical pathology.

lesionsbreast pathology: columnar cell

J. Reis-Filho, S. Pinder, 2009 .

Lobular in situ neoplasia and columnar cell lesions: diagnosis in breast core biopsies and implications for management

J. Reis-Filho, E. Provenzano, S. Pinder, 2007, Pathology.

Non-operative breast pathology: columnar cell lesions

J. Reis-Filho, S. Pinder, J S Reis-Filho, 2006, Journal of Clinical Pathology.

Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast

Sunil Badve, Laura C Collins, S. Pinder, 2006, Modern Pathology.

Challenges in the management of pleomorphic lobular carcinoma in situ of the breast.

A. Purushotham, S. Pinder, Y. Masannat, 2013, Breast.

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

Ian O Ellis, I. Ellis, S. Pinder, 2005, Modern Pathology.

Sections of the nipple and quadrants in mastectomy specimens for carcinoma are of limited value

I. Ellis, S. Pinder, C. Elston, 2005, Journal of Clinical Pathology.

An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.

I. Ellis, S. Pinder, Andrew H. S. Lee, 2003, Human pathology.

Pathology of High-Risk Breast Lesions

S. Pinder, A. Shaaban, 2018 .

Non-operative breast pathology

J. Reis-Filho, S. Pinder, J. Reis-Filho, 2006, Journal of Clinical Pathology.

"Inflammatory" breast cancer.

A. Purushotham, S. Pinder, M. Cariati, 2005, Surgical oncology.

Application of Finite Difference Time Domain methods to Terahertz Spectroscopy Measurements of Breast Cancer

S. Pinder, E. Pickwell-MacPherson, E. Pickwell‐MacPherson, 2007, 2007 IEEE/MTT-S International Microwave Symposium.

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.

F J Gilbert, C Fraser, S. Pinder, 2011, Health technology assessment.

Pathological assessment of sentinel lymph-node biopsies in patients with breast cancer

I. Ellis, S. Pinder, C. Elston, 2000, Virchows Archiv.

Comparative Immunohistochemical Analysis of Ochratoxin A Tumourigenesis in Rats and Urinary Tract Carcinoma in Humans; Mechanistic Significance of p-S6 Ribosomal Protein Expression

S. Pinder, C. Gillett, P. Gazinska, 2012, Toxins.

Lyve-1 expressing perivascular macrophages orchestrate pericyte expansion to sustain angiogenesis in cancer

S. Pinder, T. Lawrence, T. Ng, 2020, bioRxiv.

Radiotherapy after mastectomy for screen-detected ductal carcinoma in situ.

G. Ball, S. Pinder, E. Sawyer, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Successful management of elderly breast cancer patients treated without radiotherapy

S. Pinder, J. Robertson, K. Cheung, 2007, World journal of surgical oncology.

Selective use of post-mastectomy flap irradiation in high-risk breast cancer patients.

R. Blamey, S. Pinder, R. Macmillan, 2005, Breast.

Contrast-enhanced refraction imaging

Luigi Rigon, Sarah E. Pinder, Fulvia Arfelli, 2004, SPIE Optics + Photonics.

Modelling Vascularity in Breast Cancer and Surrounding Stroma Using Diffusion MRI and Intravoxel Incoherent Motion

David J. Hawkes, John H. Hipwell, Andrew Evans, 2014, Digital Mammography / IWDM.

Needle core biopsy of the breast

I. Ellis, S. Pinder, C. Elston, 2000 .

When have mammographic calcifications been adequately sampled at needle core biopsy?

I. Ellis, S. Pinder, M. Bagnall, 2000, Clinical radiology.

Digital imaging improves upright stereotactic core biopsy of mammographic microcalcifications.

I. Ellis, S. Pinder, R. Blamey, 2000, Clinical radiology.

Pathological-radiological correlations in benign lesions excised during a breast screening programme.

I. Ellis, L. Yeoman, S. Pinder, 1994, Clinical radiology.

Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial

J. Cuzick, S. Pinder, I. Fentiman, 2021, Clinical Cancer Research.

The Role of Blood Tumor Marker Measurement (Using a Biochemical Index Score and C-Erbb2) in Directing Chemotherapy in Metastatic Breast Cancer

S. Pinder, R. Blamey, S. Pinder, 2000, The International journal of biological markers.

Prognostic significance of serum c-erbB-2 protein in breast cancer patients

I. Ellis, R. Blamey, S. Pinder, 2005, Breast Cancer Research and Treatment.

The expression of alpha B‐crystallin in epithelial tumours: A useful tumour marker?

S. Pinder, J. Lowe, M. Balsitis, 1994, The Journal of pathology.

Frequency of Pathogenic Germline Variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in Sporadic Lobular Breast Cancer

S. Pinder, M. Simpson, E. Sawyer, 2019, Cancer Epidemiology, Biomarkers & Prevention.

Abstract S3-01: The TNT trial: A randomized phase III trial of carboplatin (C) compared with docetaxel (D) for patients with metastatic or recurrent locally advanced triple negative orBRCA1/2breast cancer (CRUK/07/012)

N. Rahman, M. Dowsett, P. Ellis, 2015 .

A first in human feasibility study of 18F-FDG Cerenkov luminescence imaging (CLI) for intraoperative assessment of tumour resection margins in breast-conserving surgery (BCS)

Sarah E. Pinder, Michael Douek, Gary Cook, 2016 .

Is ipsilateral mammography worthwhile in Paget's disease of the breast?

I. Ellis, L. Yeoman, S. Pinder, 1996, Clinical radiology.

Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study

L. Holmberg, M. Dowsett, A. Purushotham, 2017, Breast Cancer Research.

Handling of Surgical Specimens

S. Pinder, A. Mulligan, F. O'Malley, 2011 .

Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?

S. Pinder, A. Sever, C. Morgan, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Optimising magnetic sentinel lymph node biopsy in an in vivo porcine model.

Q. Pankhurst, S. Pinder, S. Vreemann, 2014, Nanomedicine : nanotechnology, biology, and medicine.

Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model

Joost J. Pouw, Q. Pankhurst, S. Pinder, 2013, Breast Cancer Research and Treatment.

In situ lobular proliferations of the breast

S. Pinder, A. Shaaban, 2018 .

Ductal carcinoma in situ: diagnosis and classification

I. Ellis, S. Pinder, G. Harris, 2004 .

Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype

D. Cozzetto, S. Pinder, J. Taylor‐Papadimitriou, 2020, Communications biology.

Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype

D. Cozzetto, S. Pinder, J. Taylor‐Papadimitriou, 2020, Communications Biology.

Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node.

S. Pinder, P. Cane, H. Helin, 2013, Human pathology.

HER 2-HER 3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER 2 IHC status

B. Kholodenko, P. Ellis, S. Pinder, 2016 .

Best Practice No 176

I. Ellis, M. Dowsett, S. Humphreys, 2004, Journal of Clinical Pathology.

Mycobacterial cervical lymphadenitis in children: can histological assessment help differentiate infections caused by non‐tuberculous mycobacteria from Mycobacterium tuberculosis?

S. Pinder, A. Colville, S. Pinder, 1993, Histopathology.

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

Bin Tean Teh, Andrew Menzies, Keiran Raine, 2014, eLife.

Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3)

I. Ellis, S. Pinder, C. Elston, 2003, Histopathology.

The impact of core-biopsy on pre-operative diagnosis rate of screen detected breast cancers.

I. Ellis, L. Yeoman, S. Pinder, 1996, Clinical radiology.

Reply to “Comment on: Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project”

S. Pinder, A. Thompson, K. Clements, 2021, British Journal of Cancer.

Modern therapies and iatrogenic changes in breast pathology

E. Provenzano, S. Pinder, 2017, Histopathology.

Atypical ductal hyperplasia, ductal carcinoma in situ and in situ atypical apocrine proliferations of the breast

I. Ellis, S. Pinder, 1996 .

Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients’ survival

A. Tutt, S. Pinder, A. Grigoriadis, 2017, Scientific Reports.

The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility

B. Kholodenko, A. Tutt, S. Pinder, 2014, Science Signaling.

Abstract OT2-3-01: The LORIS trial: A multicentre, randomized phase III trial of standard surgery versus active monitoring in women with newly diagnosed low risk ductal carcinoma in situ

S. Pinder, M. Wallis, L. Fallowfield, 2013 .

Proliferative activity in invasive breast carcinoma.

I. Ellis, S. Pinder, C. Elston, 1996, Journal of clinical pathology.

Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.

R W Blamey, I. Ellis, R. Blamey, 2006, European journal of cancer.

Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer

I. Ellis, S. Pinder, R. Rampaul, 2001, Breast Cancer Research.

‘Breast cancer biomarkers in clinical testing: analysis of a UK NEQAS ICC & ISH database containing results from 199 300 patients’

M. Dowsett, S. Pinder, J. Bartlett, 2020, The journal of pathology. Clinical research.

Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients

M. Dowsett, S. Pinder, J. Bartlett, 2018, The journal of pathology. Clinical research.

PP-3-20 local excision with a 10 mm margin as sole treatment for ductal carcinoma in situ (dcis) of the breast

I. Ellis, R. Blamey, S. Pinder, 1996 .

Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.

S. Pinder, E. Sawyer, P. Carder, 2018, Breast.

The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project.

S. Pinder, E. Sawyer, A. Evans, 2016, Breast.

Beneficial Effect of Tamoxifen for Women with DCIS: Long-Term Results from the UK/ANZ DCIS Trial in Women with Locally Excised DCIS.

J. Cuzick, J. Forbes, I. Ellis, 2009 .

Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

Julian Peto, Matthias W. Beckmann, Peter A. Fasching, 2014, PLoS genetics.

The impact of human epidermal growth factor receptor 2 neoadjuvant monoclonal antibody (trastuzumab) therapy in ductal carcinoma in situ of the breast

S. Pinder, D. Parham, 2017, Histopathology.

Pure mucinous breast cancer-mammographic and ultrasound findings.

I. Ellis, L. Yeoman, S. Pinder, 1996, Clinical radiology.

NIHMS662581-supplement-Supplementary data

Pardeep Kumar, Elizabeth Anderson, Jon W. Teague, 2016 .

Invasive Lobular Carcinoma of the Breast.

S. Pinder, M. Philippidou, 2012, Surgical pathology clinics.

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

Jacco, P. A. Futreal, P. Kristel, 2022, Nature Genetics.

Breast screening atypia and subsequent development of cancer: protocol for an observational analysis of the Sloane database in England (Sloane atypia cohort study)

E. Provenzano, S. Pinder, M. Wallis, 2022, BMJ Open.

Brain metastases from breast cancer: identification of a high-risk group.

S. Pinder, K. Cheung, E. Gutteridge, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low‐grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR)

S. Pinder, P. Watson, E. Rakha, 2022, Histopathology.

Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup – the “ATRESS” phenomenon

L. Holmberg, A. Purushotham, S. Pinder, 2019, Breast.

Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer

I. Ellis, M. Dowsett, A. Tutt, 2014, Breast Cancer Research and Treatment.

NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions).

S. Pinder, A. Lee, N. Sharma, 2018, Clinical radiology.

MULTISCALE BIPHASIC MODELLING OF TUMOUR GROWTH: THE EFFECT OF COLLAGEN MICROMECHANICS ON DRUG DELIVERY

David J. Hawkes, John H. Hipwell, Rebecca J. Shipley, 2016 .

Basophil activation test in cancer patient blood evaluating potential hypersensitivity to an anti‐tumor IgE therapeutic candidate

Kristina M. Ilieva, S. Pinder, J. Spicer, 2020, Allergy.

Pathological Nipple Discharge

S. Pinder, I. Fentiman, H. Hamed, 2014 .

Magnetic Technique for Sentinel Lymph Node Biopsy in Melanoma: The MELAMAG Trial

Q. Pankhurst, P. Dziewulski, S. Pinder, 2016, Annals of Surgical Oncology.

Breast Cancer with Neoductgenesis: Histopathological Criteria and Its Correlation with Mammographic and Tumour Features

S. Pinder, T. Tot, C. Blomqvist, 2014, International journal of breast cancer.

Reading the prognosis of the individual with breast cancer.

G. Ball, I. Ellis, R. Blamey, 2007, European journal of cancer.

Guidelines for the handling of benign and malignant surgical breast specimens

E. Provenzano, S. Pinder, 2007 .

HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

I. Ellis, S. Pinder, B. Jasani, 2011, Journal of Clinical Pathology.

A review of ablative techniques in the treatment of breast fibroadenomata

S. Pinder, M. Douek, Muneer Ahmed, 2016, Journal of therapeutic ultrasound.

Radiotherapy and/or Tamoxifen after conserving surgery for breast cancers of excellent prognosis: BASO II trial

I. Ellis, S. Pinder, U. Chetty, 2007 .

Abstract S2-03: Preoperative window of opportunity study of the PI3K inhibitor pictilisib (GDC-0941) plus anastrozole vs anastrozole alone in patients with ER+, HER2-negative operable breast cancer (OPPORTUNE study)

A. Purushotham, S. Pinder, A. Thompson, 2015 .

The B3 conundrum-the radiologists' perspective.

S. Pinder, L. Wilkinson, N. Sharma, 2017, The British journal of radiology.

BJRD16595 1..5

S. Pinder, L. Wilkinson, N. Sharma, 2017 .

A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up.

I. Ellis, S. Pinder, R. Blamey, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Addendum to BASOII Trial report.

S. Duffy, S. Pinder, T. Bates, 2014, European journal of cancer.

HER2 testing for breast carcinoma: recommendations for rapid diagnostic pathways in clinical practice

S. Pinder, J. Bartlett, A. Thompson, 2013, Journal of Clinical Pathology.

Fibroepithelial Lesions, Including Fibroadenoma and Phyllodes Tumors

S. Pinder, A. Mulligan, F. O'Malley, 2011 .

Chapter 2 – Diagnostic Methodologies: Core Biopsy and Handling of Surgical Specimens

S. Pinder, F. O'Malley, 2006 .

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time

L. Holmberg, A. Purushotham, S. Pinder, 2016, British Journal of Cancer.

Edinburgh Research Explorer Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50years

S. Pinder, M. Simpson, E. Sawyer, 2019 .

Non-operative diagnosis has become the norm in breast disease assessment and , until relatively recently , fine needle aspiration cytology

I. Ellis, M. Michell, S. Humphreys, 2004 .

Radiological features of papillary carcinoma of the breast.

I. Ellis, L. Yeoman, S. Pinder, 1997, Clinical radiology.

Low‐grade adenosquamous carcinoma arising in association with a nipple adenoma

S. Pinder, M. Wilsher, A. Desai, 2019, Histopathology.

Chapter 11 – Benign Stromal Lesions of the Breast

S. Pinder, A. Mulligan, F. O'Malley, 2006 .

Invasive Carcinoma: Special Types

S. Pinder, F. O'Malley, G. Harris, 2006 .

All-cause mortality rates

S. Pinder, F. Gilbert, C. Robertson, 2011 .

Adenomyoepithelioma of the breast; a case report and literature review.

I. Ellis, A. Purushotham, S. Pinder, 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

An Immunohistochemical and Fluorescence In Situ Hybridization-based Comparison Between the Oracle HER2 Bond Immunohistochemical System, Dako HercepTest, and Vysis PathVysion HER2 FISH Using Both Commercially Validated and Modified ASCO/CAP and United Kingdom HER2 IHC Scoring Guidelines

E. Provenzano, S. Pinder, L. Happerfield, 2010, Applied immunohistochemistry & molecular morphology : AIMM.

Editorial

S. Pinder, 2008 .

Diagnostic, predictive and prognostic breast pathology. Editorial.

S. Pinder, 2008, Histopathology.

Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes

S. Pinder, S. Tsoka, S. Canevari, 2022, British Journal of Cancer.

The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2022, Histopathology.

2007 IEEE/MTT-S INTERNATIONAL MICROWAVE SYMPOSIUM DIGEST, VOLS 1-6

Vincent P. Wallace, Emma Pickwell-MacPherson, Elena Provenzano, 2007, IMS 2007.

Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?

I. Ellis, S. Pinder, A. Evans, 2001, Journal of medical screening.

Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.

Michael A. Gonzalez, S. Vowler, S. Pinder, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gamma linolenic acid with tamoxifen as primary therapy in breast cancer

I. Ellis, S. Pinder, J. Robertson, 1998, International journal of cancer.

Streptococcal perianal infection in children

S. Pinder, R. Lehman, 2009, BMJ : British Medical Journal.

Review of the national external quality assessment (EQA) scheme for breast pathology in the UK

Ian O Ellis, I. Ellis, S. Pinder, 2016, Journal of Clinical Pathology.

Updated UK Recommendations for HER2 assessment in breast cancer

John M S Bartlett, Andrew Hanby, Elena Provenzano, 2014, Journal of Clinical Pathology.

Mucins in prostatic carcinoma

S. Pinder, R. McMahon, 1990, Histopathology.

Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.

A. Purushotham, S. Pinder, T. Wilson, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up.

I. Ellis, S. Pinder, B. Gusterson, 1998, Human pathology.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Päivi Heikkilä, Carlos Caldas, Arto Mannermaa, 2014, The journal of pathology. Clinical research.

Are Medullary Breast Cancers an Indication for BRCA1 Mutation Screening? A Mutation Analysis of 42 Cases of Medullary Breast Cancer

I. Ellis, S. Pinder, R. Blamey, 2004, Breast Cancer Research and Treatment.

Prognostic factors for patients with hepatic metastases from breast cancer

S. Pinder, A. Evans, K. Cheung, 2003, British Journal of Cancer.

Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in the TNT trial

M. Cheang, A. Tutt, S. Pinder, 2020 .

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.

A. Ashworth, M. Cheang, A. Tutt, 2015, Cancer discovery.

Genomic Complexity Profi ling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Defi ciency in Triple-Negative Breast Cancers

A. Ashworth, M. Cheang, A. Tutt, 2015 .

Macroscopic handling and reporting of breast cancer specimens pre‐ and post‐neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches

S. Pinder, E. Rakha, J. Bartlett, 2015, Histopathology.

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo

M. Hurles, A. Børresen-Dale, M. Stratton, 2017, Nature.

Geminin predicts adverse clinical outcome in breast cancer by reflecting cell‐cycle progression

Michael A. Gonzalez, S. Vowler, S. Chin, 2004, The Journal of pathology.

Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication

A. Purushotham, S. Pinder, R. Salgado, 2021, NPJ breast cancer.

Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients

R. Scott, S. Pinder, A. Grigoriadis, 2018, Breast Cancer Research.

HER-2 in breast cancer--methods of detection, clinical significance and future prospects for treatment.

I. Ellis, S. Pinder, J. Robertson, 2002, Critical reviews in oncology/hematology.

Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression

S. Pinder, T. Lawrence, T. Ng, 2021, Science advances.

Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis

S. Pinder, A. Grigoriadis, S. Rane, 2015, Breast Cancer Research and Treatment.

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years

S. Pinder, M. Simpson, E. Sawyer, 2019, Breast Cancer Research.

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Paul Ellis, Nazneen Rahman, Alexander Gutin, 2018, Nature Medicine.

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer

A. Børresen-Dale, I. Ellis, M. Dunning, 2014, Molecular oncology.

Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer

A. Tutt, S. Pinder, A. Grigoriadis, 2018, Clinical Cancer Research.

Spatial genomics maps the structure, character and evolution of cancer clones

P. Campbell, L. Yates, A. Richardson, 2021, bioRxiv.

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

S. Pinder, M. Simpson, E. Sawyer, 2017, Breast Cancer Research.

Current issues in diagnostic breast pathology

I. Ellis, S. Pinder, R. Walker, 2012, Journal of Clinical Pathology.

Invasive micropapillary carcinoma of breast: case report with literature review.

A. Purushotham, S. Pinder, N. de Silva, 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team.

I. Ellis, S. Pinder, C. Elston, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Preoperative assessment of prognostic factors in breast cancer

I. Ellis, S. Pinder, C. Elston, 2001, Journal of clinical pathology.

Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.

A. Tutt, S. Pinder, A. Grigoriadis, 2011, Cancer research.

Alpha‐6 integrin is necessary for the tumourigenicity of a stem cell‐like subpopulation within the MCF7 breast cancer cell line

Carlos Caldas, Anand D Purushotham, C. Caldas, 2008, International journal of cancer.

Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.

S. Pinder, M. Wallis, A. Evans, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Problematic Core Biopsies

S. Pinder, 2017 .

Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation.

I. Ellis, S. Pinder, C. Elston, 1994, Radiology.

The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification

Ian O Ellis, I. Ellis, S. Pinder, 2003, Breast Cancer Research.

Loss of Heterozygosity in Bilateral Breast Cancer

I. Ellis, R. Blamey, S. Pinder, 2000, Breast Cancer Research and Treatment.

Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia

E. Provenzano, S. Pinder, M. Wallis, 2022, BMJ Open.

Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study

E. Provenzano, S. Pinder, M. Wallis, 2022, Breast.

Variability in grading of ductal carcinoma in situ among an international group of pathologists

S. Pinder, J. Bart, S. Krishnamurthy, 2021, The journal of pathology. Clinical research.

Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project

E. Provenzano, S. Pinder, M. Wallis, 2020, British Journal of Cancer.

Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project.

G. Ball, S. Lakhani, S. Pinder, 2018, European journal of cancer.

Addressing overtreatment of screen detected DCIS; the LORIS trial.

S. Pinder, M. Wallis, D. Rea, 2015, European journal of cancer.

Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast.

G. Ball, S. Pinder, M. Wallis, 2014, European journal of cancer.

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

J. Cuzick, J. Forbes, I. Ellis, 2010, The Lancet. Oncology.

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial

J. Cuzick, J. Forbes, I. Ellis, 2010, British Journal of Cancer.

Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme

I. Ellis, S. Pinder, E. Rakha, 2017, Histopathology.

Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells

S. Pinder, G. Dontu, M. Wicha, 2014, Stem cell reports.

Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium

S. Pinder, G. Dontu, C. Ginestier, 2014, Breast Cancer Research.

Bilateral Inflammatory Pseudotumour of the Breast: A Case Report and Review of the Literature.

S. Pinder, I. Fentiman, M. Dani, 2018, European journal of breast health.

Genomic profiling defines variable clonal relatedness between invasive breast cancer and primary ductal carcinoma in situ

P. Kristel, S. Nik-Zainal, S. Pinder, 2021, medRxiv.

Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody

Ian O. Ellis, Sarah E. Pinder, S. Pinder, 1997 .

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

I. Ellis, R. Blamey, S. Pinder, 1995, British Journal of Cancer.

Abstract 313: Regulation of p53 Tetramerization and Nuclear Export by ARC

I. Ellis, S. Chin, C. Caldas, 2006 .

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

Carlos Caldas, Ian O. Ellis, Sarah E. Pinder, 2006, Clinical Cancer Research.

Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.

R W Blamey, G. Ball, I. Ellis, 2007, European journal of cancer.

HER2 status in breast cancer–an example of pharmacogenetic testing

S. Pinder, R. Zimmern, M. Kroese, 2007, Journal of the Royal Society of Medicine.

Models of Breast Morphogenesis Based on Localization of Stem Cells in the Developing Mammary Lobule

A. Csikász-Nagy, S. Pinder, T. Schiavinotto, 2015, Stem cell reports.

A Long Breast Cancer Remission without Standard Therapy

S. Pinder, I. Fentiman, M. Baum, 2015 .

Family history of breast cancer and its association with disease severity and mortality

L. Holmberg, A. Purushotham, S. Pinder, 2016, Cancer medicine.

Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles

Anita Grigoriadis, Patrycja Gazinska, L. Holmberg, 2013, Modern Pathology.

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

I. Ellis, S. Pinder, Z. Madjd, 2005, International journal of cancer.

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.

S. Duffy, R. Blamey, S. Pinder, 2013, European journal of cancer.

Comparison of margin assessment by radial and shave sections in wide local excision specimens for invasive carcinoma of the breast

S. Pinder, C. Elston, R. Macmillan, 2010, Histopathology.

ONCOPOOL - a European database for 16,944 cases of breast cancer.

M. J. van de Vijver, G. Ball, I. Ellis, 2010, European journal of cancer.

MYC amplification in breast cancer: a chromogenic in situ hybridisation study

Robin L. Jones, J. Reis-Filho, S. Pinder, 2006, Journal of Clinical Pathology.

Upregulation of MICA on high-grade invasive operable breast carcinoma.

I. Ellis, S. Pinder, Z. Madjd, 2007, Cancer immunity.

Is mammographic spiculation an independent, good prognostic factor in screening-detected invasive breast cancer?

Ian O Ellis, Andrew J Evans, I. Ellis, 2006, AJR. American journal of roentgenology.

Impact of a national external quality assessment scheme for breast pathology in the UK

I. Ellis, S. Humphreys, S. Pinder, 2006, Journal of Clinical Pathology.

Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?

I. Ellis, S. Pinder, J. Ronan, 2005, Cancer Immunology, Immunotherapy.

Patterns of metastatic breast carcinoma: influence of tumour histological grade.

S. Pinder, K. Cheung, J. James, 2004, Clinical radiology.

Expression of E2F‐4 in invasive breast carcinomas is associated with poor prognosis

I. Ellis, S. Pinder, J. Robertson, 2004, The Journal of pathology.

I. Ellis, R. Blamey, S. Pinder, 2004, Breast Cancer Research and Treatment.

Loss of CD55 Is Associated with Aggressive Breast Tumors

Ian O Ellis, Ian Spendlove, I. Ellis, 2004, Clinical Cancer Research.

Metastatic carcinoma of the breast with tubular features: differences compared with metastatic ductal carcinoma of no specific type.

S. Pinder, K. Cheung, E. Gutteridge, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast

S. Lakhani, S. Pinder, R. Millis, 2004, British Journal of Cancer.

Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast Carcinoma

I. Ellis, S. Pinder, C. Elston, 2003, The American journal of surgical pathology.

Neuroendocrine differentiation and prognosis in breast adenocarcinoma

I. Ellis, S. Pinder, C. Elston, 2002, Histopathology.

E-cadherin as a prognostic indicator in primary breast cancer

R. Blamey, S. Pinder, J. Robertson, 2001, British Journal of Cancer.

c-erbB-4 protein expression in human breast cancer

I. Ellis, R. Blamey, S. Pinder, 2000, British Journal of Cancer.

Prognostic factors in invasive carcinoma of the breast.

I. Ellis, S. Pinder, C. Elston, 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).

The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours.

I. Ellis, S. Pinder, C. Elston, 1997, British Journal of Cancer.

Histological grading of breast carcinomas: a study of interobserver agreement.

S. Pinder, C. Elston, P. Robbins, 1995, Human pathology.

A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples.

R W Blamey, R. Blamey, S. Pinder, 1995, Human pathology.

Local recurrence after simple mastectomy

I. Ellis, R. Blamey, S. Pinder, 1994, The British journal of surgery.

Abstract S6-01:BRCA1methylation status, silencing and treatment effect in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)

A. Ashworth, C. Perou, N. Rahman, 2017 .

Histological risk factors, prognostic indicators and staging

I. Ellis, S. Pinder, E. Rakha, 2013 .

RORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers.

P. Ellis, A. Tutt, S. Pinder, 2017, Cancer research.

P‐glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidism

S. Pinder, L. Happerfield, K. Balan, 2007, The British journal of surgery.

Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.

S. Pinder, C. Gillett, Virginia Tajadura, 2016, International journal of oncology.

High‐resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry

I. Ellis, S. Pinder, E. Rakha, 2005, International journal of cancer.

Endocrine response and resistance in breast cancer: a role for the transcription factor Fos

I. Ellis, S. Pinder, J. Robertson, 1999, International journal of cancer.

Change in Expression of ER, bcl-2 and MIB1 on Primary Tamoxifen and Relation to Response in ER Positive Breast Cancer

I. Ellis, S. Pinder, J. Robertson, 2004, Breast Cancer Research and Treatment.

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status

Borivoj Vojnovic, Boris N. Kholodenko, Lan K. Nguyen, 2016, Oncotarget.

Molecular classification of breast carcinoma based on the protein expression immunoprofiles

G. Ball, I. Ellis, S. Pinder, 2004 .

Prognostic factors in primary breast carcinoma.

I. Ellis, S. Pinder, C. Elston, 1995, Journal of clinical pathology.

Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer

S. Pinder, R. Macmillan, A. Wilson, 2003, British Journal of Cancer.

Invasion in breast lesions: the role of the epithelial–stroma barrier

Kylie L. Gorringe, I. Ellis, P. Tan, 2018, Histopathology.

Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy.

M. Dowsett, S. Pinder, W. Symmans, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

I. Ellis, S. Pinder, R. Blamey, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine model

Joost J. Pouw, Q. Pankhurst, S. Pinder, 2015, International journal of nanomedicine.

Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in Practice.

S. Pinder, J. Dixon, I. Macpherson, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?

I. Ellis, R. Blamey, S. Pinder, 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial.

J. Donovan, S. Pinder, H. Earl, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

HER2 testing in the UK: further update to recommendations

I. Ellis, M. Dowsett, S. Pinder, 2008, Journal of Clinical Pathology.

Updated recommendations for HER2 testing in the UK

Anthony Rhodes, Ian O. Ellis, Bharat Jasani, 2004 .

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

I. Ellis, S. Pinder, C. Elston, 1996, British Journal of Cancer.

recommendationstesting in the UK: further update to

I. Ellis, M. Dowsett, S. Pinder, 2008 .

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol

D Barnes, T Anderson, S. Pinder, 2000, Journal of clinical pathology.

Ductal carcinoma in situ: current morphological and molecular subtypes

S. Pinder, John P. Brown, 2012 .

Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?

A. Purushotham, S. Pinder, A. Goldhirsch, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1.

A Haines, I. Ellis, S. Pinder, 2004, Breast.

Recommendations for HER 2 assessment in breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2015 .

Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment

A. Tutt, S. Pinder, R. Natrajan, 2021, npj Breast Cancer.

Proteomics of REPLICANT perfusate detects changes in the metastatic lymph node microenvironment

A. Tutt, S. Pinder, R. Natrajan, 2021, NPJ breast cancer.

Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team.

D N Poller, I. Ellis, L. Yeoman, 1993, Clinical radiology.

The role of the pathologist in assessing prognostic factors for breast cancer

S. Pinder, C. Elston, G. Harris, 2008 .

Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases

I. Ellis, E. Provenzano, S. Pinder, 2021, British Journal of Cancer.

Chapter 3 – Assessment of Fine Needle Aspiration Cytology and Core Biopsy Samples

S. Pinder, F. O'Malley, 2006 .

Real‐time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study

A. Tutt, S. Pinder, R. Natrajan, 2019, The Journal of pathology.

Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer

A. Tutt, S. Pinder, S. Tsoka, 2021, Cancer Research.

Original Article Brain Metastases from Breast Cancer: Identification of a High-risk Group

S. Pinder, K. Cheung, E. Gutteridge, 2004 .

The radiological appearances of invasive cribriform carcinoma of the breast. Nottingham Breast Team.

I. Ellis, L. Yeoman, S. Pinder, 1994, Clinical radiology.

Spindle cell carcinoma of the breast: a case series of a rare histological subtype.

S. Pinder, A. Evans, J. Robertson, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Breast implant‐associated anaplastic large cell lymphoma (BIA‐ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management

I. Ellis, E. Provenzano, S. Pinder, 2019, Histopathology.

Histological risk factors, prognostic indicators

I. Ellis, S. Pinder, 2005 .

Chapter 10 – Fibroepithelial Lesions, Including Fibroadenoma and Phyllodes Tumor

S. Pinder, A. Mulligan, F. O'Malley, 2006 .

Size of invasive breast cancer and risk of local recurrence after breast-conservation therapy.

S. Pinder, R. Macmillan, K. Asgeirsson, 2003, European journal of cancer.

Oncological Outcomes in Rats Given Nephrocarcinogenic Exposure to Dietary Ochratoxin A, Followed by the Tumour Promoter Sodium Barbital for Life: A Pilot Study

S. Pinder, C. Gillett, P. Mantle, 2010, Toxins.

Genetic predisposition to ductal carcinoma in situ of the breast

S. Cross, M. Beckmann, P. Fasching, 2016, Breast Cancer Research.

Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right.

S. Pinder, D. Rea, E. Rakha, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Immunohistochemistry for Triple-Negative Breast Cancer.

S. Pinder, K. Naidoo, 2016, Methods in molecular biology.

Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time

L. Holmberg, A. Purushotham, S. Pinder, 2015, British Journal of Cancer.

Micro- and macro-metastasis in the axillary lymph node: A review.

S. Pinder, K. Naidoo, 2017, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

Over-expression of ST3Gal-I promotes mammary tumorigenesis

S. Pinder, I. Brockhausen, J. Taylor‐Papadimitriou, 2010, Glycobiology.

Leaders Prognostic factors in primary breast carcinoma

S. Pinder, C. Elston, 2022 .

Diagnostic concordance of reporting lymphovascular invasion in breast cancer

I. Ellis, S. Pinder, E. Rakha, 2018, Journal of Clinical Pathology.

Sentinel node biopsy for breast cancer may have little to offer four-node-samplers. results of a prospective comparison study.

I. Ellis, R. Blamey, S. Pinder, 2001, European journal of cancer.

Predictors of response to second-line endocrine therapy for breast cancer

I. Ellis, S. Pinder, C. Elston, 1997, Breast Cancer Research and Treatment.

Reading the prognosis of the individual with breast cancer.

G. Ball, I. Ellis, R. Blamey, 2007, European journal of cancer.

Experts and performance in histopathology--a study in breast pathology.

S. Pinder, A. J. Robertson, C. Wells, 2010, Pathology, research and practice.

The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal

I. Ellis, S. Humphreys, S. Pinder, 2006, Journal of Clinical Pathology.

Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography.

I. Ellis, S. Pinder, A. Evans, 1999, Clinical Radiology.

Best Practice No 179

I. Ellis, M. Michell, S. Humphreys, 2004, Journal of Clinical Pathology.

Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation

S. Pinder, 2010, Modern Pathology.

Breast: Ductal Carcinoma In Situ (DCIS)

S. Pinder, John P. Brown, 2011 .

Implications of Inconsistent Measurement of ER Status in Non‐Invasive Breast Cancer: A Study of 1,684 Cases from the Sloane Project

I. Ellis, S. Pinder, K. Clements, 2008, The breast journal.

Ductal Carcinoma in Situ

S. Pinder, A. Thompson, S. Carter, 2018 .

Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins?

I. Ellis, A. Green, S. Pinder, 2017, Histopathology.

Proliferative Breast Lesions

S. Pinder, 2017 .

Accuracy of mammography in predicting histological extent of ductal carcinoma in situ (DCIS).

I. Ellis, S. Pinder, R. Macmillan, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings

I. Ellis, S. Pinder, A. Evans, 2001, British Journal of Cancer.

Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.

I. Ellis, S. Pinder, R. Blamey, 1999, European journal of cancer.

Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.

S. Pinder, C. Elston, A. Evans, 1994, AJR. American journal of roentgenology.

Pre-operative diagnosis of breast cancer in screening: problems and pitfalls.

E. Provenzano, S. Pinder, 2009, Pathology.

The SMALL Trial: A Big Change for Small Breast Cancers.

S. Pinder, D. Rea, S. Taylor-Phillips, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

Guidelines for breast needle core biopsy handling and reporting in breast screening assessment

I. Ellis, M. Michell, S. Humphreys, 2004 .

Systematic review of high‐intensity focused ultrasound ablation in the treatment of breast cancer

A. Napoli, S. Pinder, B. Ten Haken, 2015, The British journal of surgery.

Diffusion anisotropy in breast cancer tissue corresponds to spatial patterns of collagen alignment from structure tensor analysis of histology

David J. Hawkes, John H. Hipwell, Daniel C. Alexander, 2017 .

Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?

I. Ellis, S. Pinder, R. Macmillan, 2003, Clinical radiology.

Mammographic and pathological features of breast cancer detected at first incident round screening

I. Ellis, L. Yeoman, R. Blamey, 1997 .

Detecting which invasive cancers at mammographic screening saves lives?

I. Ellis, S. Pinder, A. Evans, 2001, Journal of medical screening.

Correlations between the mammographic features of screen detected invasive breast cancer and pathological prognostic factors

I. Ellis, L. Yeoman, S. Pinder, 1997 .

Screening interval breast cancers: mammographic features and prognosis factors.

L J Yeoman, R W Blamey, I. Ellis, 1996, Radiology.

98. Mammographic features of interval cancers and prognosis compared with screen detected and symptomatic breast cancers

L. Yeoman, R. Blamey, S. Pinder, 1995 .

A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going?

I. Ellis, S. Pinder, C. Elston, 1999, Seminars in diagnostic pathology.

Pathological Examination of Sentinel Lymph Nodes: Work-Up – Interpretation – Clinical Implications

J. Nährig, H. Höfler, M. Dietel, 2007, Breast Care.

Sentinel Node Biopsy Using a Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial

Q. Pankhurst, P. Drew, A. Purushotham, 2014, Annals of Surgical Oncology.

Classification of terahertz-pulsed imaging data from excised breast tissue.

Vincent P Wallace, Anthony J Fitzgerald, Sarah Pinder, 2012, Journal of biomedical optics.

Is mammography of value in women with disseminated cancer of unknown origin?

S. Pinder, H. Denley, A. Evans, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

The importance of histological assessment after neoadjuvant therapy and the need for standardisation.

S. Pinder, K. Naidoo, 2018, Clinical radiology.

An audit of residual cancer burden reproducibility in a UK context

S. Pinder, D. Parham, K. Naidoo, 2017, Histopathology.

The Importance of Post Neoadjuvant Histological Assessment and Need for Standardisation

S. Pinder, K. Naidoo, 2017 .

Genetic predisposition to ductal carcinoma in situ of the breast

S. Cross, M. Beckmann, A. Børresen-Dale, 2016, Breast Cancer Research.

Breast cancer diagnosis using scattered X‐rays

David R. Dance, Chris Hall, Keith Rogers, 2000 .

Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value

S. Pinder, A. Grigoriadis, C. Gillett, 2015, BMC Cancer.

PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion

S. Pinder, S. Eccles, G. Box, 2015, The Journal of cell biology.

Delay to fixation of invasive breast carcinoma: Effect on mitotic count, MIB1, ER and P53 expression

I. Ellis, S. Pinder, C. Elston, 2001 .

An audit of grading and typing of invasive breast carcinoma on needlecore biopsy specimens

I. Ellis, S. Pinder, H. Denley, 1998 .

UK recommendations for HER2 assessment in breast cancer: an update

I. Ellis, P. Tan, E. Provenzano, 2022, Journal of Clinical Pathology.

Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial

S. Pinder, M. Wallis, D. Rea, 2017, Annals of Surgical Oncology.

Chapter 17 – Morphology of Ductal Carcinoma in situ

S. Pinder, F. O'Malley, 2006 .

The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project

I. Ellis, E. Provenzano, S. Pinder, 2022, British Journal of Cancer.

Correlation between immunohistochemical and fish analysis for HER-2 in 441 breast carcinomas from multiple hospitals

I. Ellis, M. Dowsett, S. Pinder, 2001 .

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

I. Ellis, E. Provenzano, S. Pinder, 2021, Modern Pathology.

Accuracy of classification of invasive lobular carcinoma on needle core biopsy of the breast

T. Stephenson, S. Pinder, C. Quinn, 2016, Journal of Clinical Pathology.

Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma.

S. Pinder, R. Macmillan, A. Evans, 2004, Clinical radiology.

O-91 Prognostic estimation: re-analysis of data from cases diagnosed in 1990–99 by Cox proportional hazards method

G. Ball, I. Ellis, A. Green, 2007 .

Screening detects a myriad of breast disease - refining practice will increase effectiveness and reduce harm.

S. Pinder, I. Lyburn, 2020, The British journal of radiology.

Are you a typer, grader or a molecular convert? Prognostic assessment of operable breast carcinoma

I. Ellis, R. Blamey, S. Pinder, 1992 .

Breast Pathology: A Volume in the Foundations in Diagnostic Pathology series

S. Pinder, A. Mulligan, F. O'Malley, 2011 .

Low-risk DCIS. What is it? Observe or excise?

S. Pinder, A. Thompson, Jelle Wesserling, 2021, Virchows Archiv.

Bilateral breast carcinomas: do they have similar mammographic features?

I. Ellis, R. Blamey, S. Pinder, 1999, Clinical radiology.

Breast calcification micromorphology classification

S. Pinder, I. Lyburn, P. Bouzy, 2022, The British journal of radiology.

Automated Classification of Breast Cancer Stroma Maturity From Histological Images

David J. Hawkes, John H. Hipwell, Norman R. Williams, 2017, IEEE Transactions on Biomedical Engineering.

Intraoperative Assessment of Tumor Resection Margins in Breast-Conserving Surgery Using 18F-FDG Cerenkov Luminescence Imaging: A First-in-Human Feasibility Study

Sarah E. Pinder, Michael Douek, Gary J. Cook, 2017, The Journal of Nuclear Medicine.

Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland

I. Ellis, E. Provenzano, S. Pinder, 2021, Journal of Clinical Pathology.

High-intensity focused ultrasound in the treatment of breast fibroadenomata (HIFU-F trial)

S. Pinder, M. Ahmed, M. Douek, 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Precursor lesions of breast carcinoma

I. Ellis, S. Pinder, F. Linell, 1993 .

Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma in situ: Results from the UK/ANZ DCIS Trial

J. Cuzick, S. Pinder, I. Fentiman, 2021, Clinical Cancer Research.

Deposition of superparamagnetic iron‐oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection

S. Pinder, M. Douek, L. Johnson, 2013, Histopathology.

Multiple foci of invasive breast cancer: can breast MRI influence surgical management?

S. Pinder, M. Douek, L. Johnson, 2011, Breast Cancer Research and Treatment.

Comments on Synchrotron fibre diffraction identifies and locates foetal collagenous breast tIssue associated with breast carcinoma by V. J. James (2002). J. Synchrotron Rad. 9, 71-76.

S. Pinder, K. Rogers, C. Hall, 2003, Journal of synchrotron radiation.

Preliminary observations of breast tumor collagen

Caroline Boggis, Chris Hall, Keith Rogers, 1999 .

Lymphatic drainage pathways of the breast and the upper limb

S. Pinder, P. Mortimer, A. Purushotham, 2009, Nuclear medicine communications.

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression

S. Pinder, M. Simpson, E. Sawyer, 2017, Breast Cancer Research.

Erratum: The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes

Bin Liu, Carlos Caldas, Arusha Oloumi, 2016, Nature Communications.

Wide local excision with 10 mm clearance without radiotherapy for DCIS

I. Ellis, S. Pinder, R. Blamey, 2001 .

Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer

G. Ball, I. Ellis, S. Pinder, 2014, Clinical Cancer Research.

Consolidated criteria for reporting qualitative research guidelines

J. Donovan, S. Pinder, A. Makris, 2016 .

Lympo-vascular invasion (LVI) and prognosis in invasive breast cancer

S. Pinder, 2002 .

Abstract P3-17-06: LORIS trial of active monitoring for DCIS: How does the online pathology eligibility review process work?

S. Pinder, A. Francis, A. Hanby, 2017 .

The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer

A. Purushotham, S. Pinder, L. Bobrow, 2005, British Journal of Cancer.

Oestrogen receptor expression in human breast cancer during long-term fulvestrant treatment.

S. Pinder, K. Cheung, E. Gutteridge, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology.

S. Pinder, C. Elston, R. Blamey, 1996, The Australian and New Zealand journal of surgery.

Exploration of utility of combined optical photothermal infrared and Raman imaging for investigating the chemical composition of microcalcifications in breast cancer

S. Pinder, J. Moger, N. Stone, 2023, Analytical methods : advancing methods and applications.

Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy.

M. Dowsett, S. Pinder, W. Symmans, 2015 .

Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up

S. Pinder, C. Elston, R. Blamey, 1994, Histopathology.

Concordance of intrinsic subtyping and risk of recurrence (ROR) scores between matched primary and metastatic tissue from Triple Negative Breast Cancer Trial (TNT).

M. Dowsett, P. Ellis, M. Cheang, 2015 .

Abstract P4-11-07: Comparison of multiparameter tests in the UK OPTIMA-Prelim trial

J. Donovan, S. Pinder, A. Makris, 2015 .

Abstract P6-08-11: UK OPTIMA-prelim study demonstrates economic value in more clinical evaluation of multi-parameter prognostic tests in early breast cancer

J. Donovan, S. Pinder, H. Earl, 2015 .

Microcalcification crystallography as a potential marker of DCIS recurrence

Lars J. Grimm, S. Pinder, Lorraine M. King, 2023, Scientific reports.

A multi-modal exploration of heterogeneous physico–chemical properties of DCIS breast microcalcifications

S. Pinder, Lorraine M. King, N. Stone, 2022, In Analysis.

Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland –on behalf of the UK national coordinating committee for breast pathology

E. Provenzano, S. Pinder, E. Rakha, 2023, Breast.

An intra-operative THz probe for use during the surgical removal of breast tumors

M. Pepper, A. Purushotham, S. Pinder, 2008, 2008 33rd International Conference on Infrared, Millimeter and Terahertz Waves.

Terahertz spectroscopy of breast tumors

E. Pickwell-MacPherson, M. Pepper, E. Pickwell‐MacPherson, 2007, 2007 Joint 32nd International Conference on Infrared and Millimeter Waves and the 15th International Conference on Terahertz Electronics.

X-ray refraction effects: application to the imaging of biological tissues.

D R Dance, F Arfelli, G Tromba, 2003, The British journal of radiology.

Loss of CD59 expression in breast tumours correlates with poor survival

S. Pinder, S. Pinder, C. Paish, 2003, The Journal of pathology.

Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients.

C Caldas, C. Caldas, S. Pinder, 2008, Breast.

High intensity focused ultrasound in the treatment of breast fibroadenomata: results of the HIFU-F trial

S. Pinder, S. Pinder, M. Ahmed, 2016, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma

S. Pinder, C. Elston, R. Blamey, 1995, Histopathology.

Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects

S. Pinder, J. Lennerz, A. Grigoriadis, 2023, The Journal of pathology.

Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large‐scale studies

S. Pinder, S. Linn, A. Grigoriadis, 2023, The Journal of pathology.

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres

M. Dowsett, S. Pinder, S. Pinder, 2003, The Journal of pathology.

Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication

A. Purushotham, S. Pinder, R. Salgado, 2021, npj Breast Cancer.

Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node‐positive breast cancers

A. Tutt, S. Pinder, A. Grigoriadis, 2018, The journal of pathology. Clinical research.